Next year, the company will pursue regulatory clearance for its wearable device, CardioTag. The company’s first application using artificial intelligence to improve the management of congestive heart failure, according to a Dec. 8 Cardiosense news release.
The financing round was co-led by Broadview Ventures and Hatteras Venture Partners. Cardiosense plans to use the financing to expand its team, accelerate product development and fund a heart failure study.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
